Dabrafenib 50 mg Oral Capsule
RxNorm 1424916
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 1424916 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: dabrafenib 50 mg Oral Capsule.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
Semantic Clinical Drug (SCD):
Dabrafenib 50 mg Oral Capsule
(Atom ID: 5469278)
Synonym (SY):
Dabrafenib (as dabrafenib mesilate) 50 mg oral capsule
(Atom ID: 10800623)
Designated preferred name (PT):
Dabrafenib (as dabrafenib mesylate) 50 mg oral capsule
(Atom ID: 10296798)
Synonym (SY):
Dabrafenib (as dabrafenib methylsulfate 59.25 mg) 50 mg Oral Capsule
(Atom ID: 5483254)
Prescribable Name (PSN):
Dabrafenib 50 mg Oral Capsule
(Atom ID: 6362991)
Full form of descriptor (FN):
Product containing precisely dabrafenib (as dabrafenib mesilate) 50 mg/1 each conventional release oral capsule (clinical drug)
(Atom ID: 10818761)
Patient Education
Dabrafenib
Dabrafenib is used alone or in combination with trametinib (Mekinist) to treat a certain types of melanoma (a type of skin cancer) that cannot be treated with surgery or that has spread to other parts of the body. It is also used along with trametinib to treat and prevent the return of a certain type of melanoma after surgery to remove it and any affected lymph nodes. Dabrafenib is also used in combination with trametinib to treat a certain type of non-small cell lung cancer (NSCLC) that has spread to nearby tissues or to other parts of the body. It is also used to treat a certain type of thyroid cancer that has spread to nearby tissues or to other parts of the body that has not responded to previous treatment(s). Dabrafenib is in a class of medications called kinase inhibitors. It works by blocking the action of an abnormal protein that signals cancer cells to multiply. This helps stop the spread of cancer cells.
[Learn More]
Cancer Chemotherapy
Normally, your cells grow and die in a controlled way. Cancer cells keep growing without control. Chemotherapy is drug therapy for cancer. It works by killing the cancer cells, stopping them from spreading, or slowing their growth. However, it can also harm healthy cells, which causes side effects.
You may have a lot of side effects, some, or none at all. It depends on the type and amount of chemotherapy you get and how your body reacts. Some common side effects are fatigue, nausea, vomiting, pain, and hair loss. There are ways to prevent or control some side effects. Talk with your health care provider about how to manage them. Healthy cells usually recover after chemotherapy is over, so most side effects gradually go away.
Your treatment plan will depend on the cancer type, the chemotherapy drugs used, the treatment goal, and how your body responds. Chemotherapy may be given alone or with other treatments. You may get treatment every day, every week, or every month. You may have breaks between treatments so that your body has a chance to build new healthy cells. You might take the drugs by mouth, in a shot, as a cream, or intravenously (by IV).
NIH: National Cancer Institute
[Learn More]
* Please review the disclaimer below.
